Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20180123Description: 1235-41 p. digitalISSN:- 1477-0970
- Adult
- Alemtuzumab -- adverse effects
- Autoimmune Diseases -- chemically induced
- Autoimmunity -- drug effects
- Humans
- Immunosuppressive Agents -- adverse effects
- Male
- Multiple Sclerosis, Relapsing-Remitting -- diagnosis
- Purpura, Thrombocytopenic, Idiopathic -- chemically induced
- Risk Factors
- Thyroid Diseases -- chemically induced
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.